Halfmann PJ - Search Results

1

Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.

Chiba S, Halfmann PJ, Iida S, Hirata Y, Sato Y, Kuroda M, Armbrust T, Spyra S, Suzuki T, Kawaoka Y. Chiba S, et al. Among authors: halfmann pj. Vaccine. 2023 Sep 22;41(41):6025-6035. doi: 10.1016/j.vaccine.2023.08.054. Epub 2023 Aug 25. Vaccine. 2023. PMID: 37635002 Free article.

2

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.

Hatta M, Gao P, Halfmann P, Kawaoka Y. Hatta M, et al. Science. 2001 Sep 7;293(5536):1840-2. doi: 10.1126/science.1062882. Science. 2001. PMID: 11546875

3

Human influenza a viral genes responsible for the restriction of its replication in duck intestine.

Hatta M, Halfmann P, Wells K, Kawaoka Y. Hatta M, et al. Virology. 2002 Apr 10;295(2):250-5. doi: 10.1006/viro.2002.1358. Virology. 2002. PMID: 12033783 Free article.

4

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y. Kobasa D, et al. Nature. 2004 Oct 7;431(7009):703-7. doi: 10.1038/nature02951. Nature. 2004. PMID: 15470432

5

Characterization of a human H5N1 influenza A virus isolated in 2003.

Shinya K, Hatta M, Yamada S, Takada A, Watanabe S, Halfmann P, Horimoto T, Neumann G, Kim JH, Lim W, Guan Y, Peiris M, Kiso M, Suzuki T, Suzuki Y, Kawaoka Y. Shinya K, et al. J Virol. 2005 Aug;79(15):9926-32. doi: 10.1128/JVI.79.15.9926-9932.2005. J Virol. 2005. PMID: 16014953 Free PMC article.

6

Regions in Ebola virus VP24 that are important for nucleocapsid formation.

Noda T, Halfmann P, Sagara H, Kawaoka Y. Noda T, et al. J Infect Dis. 2007 Nov 15;196 Suppl 2:S247-50. doi: 10.1086/520596. J Infect Dis. 2007. PMID: 17940956

7

Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.

Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y. Watanabe S, et al. J Infect Dis. 2007 Nov 15;196 Suppl 2:S284-90. doi: 10.1086/520582. J Infect Dis. 2007. PMID: 17940962

8

Generation of biologically contained Ebola viruses.

Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y. Halfmann P, et al. Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1129-33. doi: 10.1073/pnas.0708057105. Epub 2008 Jan 22. Proc Natl Acad Sci U S A. 2008. PMID: 18212124 Free PMC article.

9

Replication-deficient ebolavirus as a vaccine candidate.

Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, Suresh M, Neumann G, Feldmann H, Kawaoka Y. Halfmann P, et al. J Virol. 2009 Apr;83(8):3810-5. doi: 10.1128/JVI.00074-09. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211761 Free PMC article.

10

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Nanbo A, et al. PLoS Pathog. 2010 Sep 23;6(9):e1001121. doi: 10.1371/journal.ppat.1001121. PLoS Pathog. 2010. PMID: 20886108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters